Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Non-cash Items: 2019-2025

Historic Non-cash Items for IDEAYA Biosciences (IDYA) over the last 7 years, with Sep 2025 value amounting to $108.4 million.

  • IDEAYA Biosciences' Non-cash Items rose 11.87% to $108.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.4 million, marking a year-over-year increase of 11.87%. This contributed to the annual value of $90.2 million for FY2024, which is 119.46% up from last year.
  • Per IDEAYA Biosciences' latest filing, its Non-cash Items stood at $108.4 million for Q3 2025, which was down 8.75% from $118.8 million recorded in Q2 2025.
  • In the past 5 years, IDEAYA Biosciences' Non-cash Items ranged from a high of $118.8 million in Q2 2025 and a low of $41,400 during Q4 2021.
  • Its 3-year average for Non-cash Items is $84.3 million, with a median of $96.9 million in 2024.
  • Data for IDEAYA Biosciences' Non-cash Items shows a peak YoY surged of 67,532.85% (in 2022) over the last 5 years.
  • Over the past 5 years, IDEAYA Biosciences' Non-cash Items (Quarterly) stood at $41,400 in 2021, then surged by 67,532.85% to $28.0 million in 2022, then skyrocketed by 46.79% to $41.1 million in 2023, then skyrocketed by 119.46% to $90.2 million in 2024, then rose by 11.87% to $108.4 million in 2025.
  • Its last three reported values are $108.4 million in Q3 2025, $118.8 million for Q2 2025, and $115.7 million during Q1 2025.